米CellMax Life社は2019年1月2日、台湾Medigen Biotech社との提携契約の下、血液検体で大腸癌の早期発見に寄与する検査技術基盤「CMx」のフェーズIを2019年下半期に開始すると発表した。契約に伴う金額的な取り決めは公表していない。 日経バイオテク（法人版）は2 ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--CellMax Life, the precision cancer testing company, announced today the commercial availability of CellMax-LBx Liquid Biopsy in India. CellMax-LBx is a cancer blood ...

Data shows 92% sensitivity for colorectal cancer and 55% sensitivity for precancerous advanced adenomas at 91% specificity. Data to be presented at ASCO Gastrointestinal Cancers Symposium The data ...

NEW YORK (360Dx) – CellMax Life announced this week that it is beginning a new clinical trial, which will further validate its circulating tumor cell (CTC) colorectal cancer screening test in American ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--CellMax Life, the precision cancer testing company, announced today the immediate availability in India of the CellMax-DNA Genetic Cancer Risk Test, which examines ...

SUNNYVALE, Calif. and TAIPEI, Taiwan, Feb. 6, 2018 /PRNewswire/ -- CellMax Life, a leading cancer diagnostics company enabling early cancer detection and management with globally affordable ...

SUNNYVALE, Calif., June 1, 2020 /PRNewswire-PRWeb/ -- CellMax Life, a molecular diagnostics company with a proprietary technology to detect pre-cancer and cancer cells in the blood, today released ...

SUNNYVALE, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- CellMax Life, a molecular diagnostics company, announced today that its FirstSight™ pre-cancer and cancer detection blood test has received ...

SUNNYVALE, Calif. and ROSWELL, Ga., March 23, 2021 /PRNewswire/ -- CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, and Sebela ...